Pre-treatment fertility preservation and post-treatment reproduction in long-term survivors of adolescent and young adult (AYA) cancer

Vicky Lehmann, Carla Vlooswijk, Winette T.A. van der Graaf, Rhodé Bijlsma, Suzanne E.J. Kaal, Jan Martijn Kerst, Jacqueline M. Tromp, Monique E.M.M. Bos, Tom van der Hulle, Roy I. Lalisang, Janine Nuver, Mathilde C.M. Kouwenhoven, Christianne A.R. Lok, Catharina C.M. Beerendonk, Marij Dinkelman-Smit, Olga Husson

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose: To describe recall of fertility-related consultations and cryopreservation and to examine reproductive goals and reproduction post-treatment in long-term survivors of adolescent and young adult (AYA) (age, 18–39 years) cancer. Methods: This study included n = 1457 male and n = 2112 female long-term survivors (M age = 43–45 years; 5–22 years from diagnosis) who provided self-report. Clinical data were supplied by the Netherlands Cancer Registry. Results: Most male survivors (72.7%) recalled fertility-related consultations and 22.6% completed sperm cryopreservation. Younger age (OR = 2.8; 95%CI [2.2–3.6]), not having children (OR = 5.0; 95%CI [3.2–7.7]), testicular cancer or lymphoma/leukemia (OR = 2.8/2.5 relative to “others”), and more intense treatments (OR = 1.5; 95%CI [1.1–2.0]) were associated with higher cryopreservation rates. Time since diagnosis had no effect. Of men who cryopreserved, 12.1% utilized assisted reproductive technologies (ART). Most men (88.5%) felt their diagnosis did not affect their reproductive goals, but 7.6% wanted no (additional) children due to cancer. Half of female survivors (55.4%; n = 1171) recalled fertility-related consultations. Rates of cryopreservation were very low (3.6%), but increased after 2013 when oocyte cryopreservation became non-experimental. Of women who cryopreserved, 13.2% successfully utilized ART. Most women (74.8%) experienced no effects of cancer on reproductive goals, but 17.8% wanted no (additional) children due to cancer. Conclusions: Cryopreservation in men varied by patient/clinical factors and was very low in women, but data of more recently treated females are needed. Utilizing cryopreserved material through ART was rare, which questions its cost-effectiveness, but it may enhance survivors’ well-being. Implications for Cancer Survivors: The extent to which cryopreservation positively affects survivors’ well-being remains to be tested. Moreover, effects of cancer on reproductive goals require further attention, especially in women who refrain from having children due to cancer.

Original languageEnglish
JournalJournal of Cancer Survivorship
Early online date2024
DOIs
Publication statusE-pub ahead of print - 2024

Keywords

  • Adolescence and young adulthood (AYA)
  • Assisted reproductive technologies (ART)
  • Fertility preservation
  • Oncology
  • Reproductive goals

Cite this